Phosphatidylethanol is Superior to Carbohydrate-Deficient Transferrin and γ-Glutamyltransferase as an Alcohol Marker and is a Reliable Estimate of Alcohol Consumption Level

Alcoholism: Clinical and Experimental Research

Volumn 39, Issue 11, 2015, Pages 2200-2208

  Walther, Lisa ^a   de Bejczy, Andrea ^b,c   Löf, Elin ^b,c   Hansson, Therese ^a   Andersson, Anders ^a   Guterstam, Joar ^d   Hammarberg, Anders ^d   Asanovska, Gulber ^a   Franck, Johan ^d   Söderpalm, Bo ^b,c   Isaksson, Anders ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alcohol Biomarker; Carbohydrate Deficient Transferrin; Phosphatidylethanol; Reported Alcohol Consumption

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL DERIVATIVE; ASPARTATE AMINOTRANSFERASE; CARBOHYDRATE DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE; PHOSPHATIDYLETHANOL; PLACEBO; UNCLASSIFIED DRUG; VARENICLINE; BIOLOGICAL MARKER; CARBOHYDRATE-DEFICIENT TRANSFERRIN; GLYCEROPHOSPHOLIPID; TRANSFERRIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DESCRIPTIVE RESEARCH; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SELF REPORT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; DRINKING BEHAVIOR; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; STANDARDS;

ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; BIOMARKERS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLYCEROPHOSPHOLIPIDS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SELF REPORT; TRANSFERRIN;

EID: 84945255488     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12883     Document Type: Article

References (51)

1. Allen JP, Wurst FM, Thon N, Litten RZ (2013) Assessing the drinking status of liver transplant patients with alcoholic liver disease. Liver Transpl 19:369-376.
2. Alling C, Chick JD, Anton R, Mayfield RD, Salaspuro M, Helander A, Harris RA (2005) Revealing alcohol abuse: to ask or to test? Alcohol Clin Exp Res 29:1257-1263.
3. Alling C, Gustavsson L, Anggard E (1983) An abnormal phospholipid in rat organs after ethanol treatment. FEBS Lett 152:24-28.
4. Alling C, Gustavsson L, Mansson J-E, Gunter B, Anggard E (1984) Phosphatidylethanol formation in rat organs after ethanol treatment. Biochim Biophys Acta 793:119-122.
5. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text rev. American Psychiatric Association, Washington, DC.
6. Andréasson S, Hansagi H, Österlund B (2002) Short-term treatment for alcohol-related problems: four-session guided self-change versus one session of advice - a randomized, controlled trial. Alcohol 28:57-62.
7. Aradottir S, Asanovka G, Gjerss S, Hansson P, Alling C (2006) Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol 41:431-437.
8. Aradottir S, Seidl S, Wurst FM, Jönsson BA, Alling C (2004) Phosphatidylethanol in human organs and blood: a study on autopsy material and influences by storage conditions. Alcohol Clin Exp Res 28:1718-1723.
9. Bajunirwe F, Haberer JE, Boum Y, Hunt P, Mocello R, Martin JN, Bangsberg DR, Hahn JA (2014) Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda. PLoS One 9:e113152.
10. Bergström JP, Helander A (2008) Clinical characteristics of carbohydrate-deficient transferrin (%disialotransferrin) measured by HPLC: sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers. Alcohol Alcohol 43:436-441.
11. Bertholet N, Winter MR, Cheng DM, Samet JH, Saitz R (2014) How accurate are blood (or breath) tests for identifying self-reported heavy drinking among people with alcohol dependence? Alcohol Alcohol 49:423-429.
12. Bortolotti F, De Paoli G, Tagliaro F (2006) Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. J Chromatogr B Analyt Technol Biomed Life Sci 841:96-109.
13. Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR (2007) AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 31:1208-1217.
14. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA (1998) The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med 158:1789-1795.
15. de Bejczy A, Löf E, Walther L, Guterstam J, Hammarberg A, Asanovska G, Franck J, Isaksson A, Söderpalm B (2015) Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial. Alcohol Clin Exp Res doi:10.1111/acer.12854.
16. Del Boca FK, Darkes J (2003) The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction 98(Suppl 2):1-12.
17. Ewing JA (1984) Detecting alcoholism. The CAGE Questionnaire. JAMA 252:1905-1907.
18. Fagan KJ, Irvine KM, McWhinney BC, Fletcher LM, Horsfall LU, Johnson L, O'Rourke P, Martin J, Scott I, Pretorius CJ, Ungerer JP, Powell EE (2014) Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers. BMC Gastroenterol 14:97.
19. Gnann H, Weinmann W, Thierauf A (2012) Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days. Alcohol Clin Exp Res 36:1507-1511.
20. Hahn JA, Dobkin LM, Mayanja B, Emenyonu NI, Kigozi IM, Shiboski S, Bangsberg DR, Gnann H, Weinmann W, Wurst FM (2012) Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol Clin Exp Res 36:854-862.
21. Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ (2007) Biochemical markers of alcoholism. Clin Chem Lab Med 45:953-961.
22. Hansson P, Caron M, Johnson G, Gustavsson L, Alling C (1997) Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal. Alcohol Clin Exp Res 21:108-110.
23. Hartmann S, Aradottir S, Graf M, Wiesbeck G, Lesch O, Ramskogler K, Wolfersdorf M, Alling C, Wurst FM (2007) Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin. Addict Biol 12:81-84.
24. Helander A, Hansson T (2013) [National harmonization of the alcohol biomarker PEth]. Läkartidningen 110:1747-1748.
25. Helander A, Husa A, Jeppsson JO (2003) Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem 49:1881-1890.
26. Helander A, Zheng Y (2009) Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS. Clin Chem 55:1395-1405.
27. Isaksson A, Walther L, Hansson T, Andersson A, Alling C (2011) Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse. Drug Test Anal 3:195-200.
28. Jain J, Evans JL, Briceno A, Page K, Hahn JA (2014) Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users. Alcohol Alcohol 49:520-524.
29. Kechagias S, Dernroth DN, Blomgren A, Hansson T, Isaksson A, Walther L, Kronstrand R, Kågedal B, Nystrom FH (2015) Phosphatidylethanol compared with other blood tests as a biomarker of moderate alcohol consumption in healthy volunteers: a prospective randomized study. Alcohol Alcohol 50:399-406.
30. Kip MJ, Spies CD, Neumann T, Nachbar Y, Alling C, Aradottir S, Weinmann W, Wurst FM (2008) The usefulness of direct ethanol metabolites in assessing alcohol intake in nonintoxicated male patients in an emergency room setting. Alcohol Clin Exp Res 32:1284-1291.
31. Marques P, Hansson T, Isaksson A, Walther L, Jones J, Lewis D, Jones M (2011) Detection of phosphatidylethanol (PEth) in the blood of drivers in an alcohol ignition interlock program. Traffic Inj Prev 12:136-141.
32. Marques P, Tippetts S, Allen J, Javors M, Alling C, Yegles M, Pragst F, Wurst F (2010) Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptives. Addiction 105:226-239.
33. Midanik LT (1988) Validity of self-reported alcohol use: a literature review and assessment. Br J Addict 83:1019-1030.
34. Nalesso A, Viel G, Cecchetto G, Mioni D, Pessa G, Favretto D, Ferrara SD (2011) Quantitative profiling of phosphatidylethanol molecular species in human blood by liquid chromatography high resolution mass spectrometry. J Chromatogr A 1218:8423-8431.
35. Northcote J, Livingston M (2011) Accuracy of self-reported drinking: observational verification of "last occasion" drink estimates of young adults. Alcohol Alcohol 46:709-713.
36. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J (2009) Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373:2223-2233.
37. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Mårtensson A, Hyltoft Petersen P, Simonsson P, Steensland H, Uldall A (2004) The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 64:271-284.
38. Saunders JB, Aasland OG, Amundsen A, Grant M (1993) Alcohol consumption and related problems among primary health care patients: WHO collaborative project on early detection of persons with harmful alcohol consumption-I. Addiction 88:349-362.
39. Sillanaukee P, van der Gaag MS, Sierksma A, Hendriks HF, Strid N, Pönniö M, Nikkari ST (2003) Effect of type of alcoholic beverages on carbohydrate-deficient transferrin, sialic acid, and liver enzymes. Alcohol Clin Exp Res 27:57-60.
40. Skipper GE, Thon N, Dupont RL, Baxter L, Wurst FM (2013) Phosphatidylethanol: the potential role in further evaluating low positive urinary ethyl glucuronide and ethyl sulfate results. Alcohol Clin Exp Res 37:1582-1586.
41. Sobell L, Sobell MB (1992) Timeline follow-back: a technique for assessing self-reported alcohol consumption, in Measuring Alcohol Consumption: Psychosocial and Biological Methods (Litten RZ, Allen J eds), pp 41-74. Humana Press, Totowa, NJ.
42. Stewart SH, Koch DG, Willner IR, Anton RF, Reuben A (2014) Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease. Alcohol Clin Exp Res 38:1706-1711.
43. Stewart SH, Law TL, Randall PK, Newman R (2010) Phosphatidylethanol and alcohol consumption in reproductive age women. Alcohol Clin Exp Res 34:488-492.
44. Stewart SH, Reuben A, Brzezinski WA, Koch DG, Basile J, Randall PK, Miller PM (2009) Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol 44:464-467.
45. Varga A, Hansson P, Johnson G, Alling C (2000) Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin Chim Acta 299:141-150.
46. Varga A, Hansson P, Lundqvist C, Alling C (1998) Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers. Alcohol Clin Exp Res 22:1832-1837.
47. Vogeser M, Parhofer KG (2007) Liquid chromatography tandem-mass spectrometry (LC-MS/MS) - technique and applications in endocrinology. Exp Clin Endocrinol Diabetes 115:559-570.
48. World Health Organization (2014) Global status report on alcohol and health 2014.World Health Organization, Geneva, Switzerland.
49. Wurst FM, Haber PS, Wiesbeck G, Watson B, Wallace C, Whitfield JB, Halter C, Weinmann W, Conigrave KM (2008) Assessment of alcohol consumption among hepatitis C-positive people receiving opioid maintenance treatment using direct ethanol metabolites and self-report: a pilot study. Addict Biol 13:416-422.
50. Wurst FM, Thon N, Aradottir S, Hartmann S, Wiesbeck GA, Lesch O, Skala K, Wolfersdorf M, Weinmann W, Alling C (2010) Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports. Addict Biol 15:88-95.
51. Zheng Y, Beck O, Helander A (2011) Method development for routine liquid chromatography-mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood. Clin Chim Acta 412:1428-1435.